MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Serum levels of polychlorinated biphenyls, CYP2B6 and neurodegenerative disease in the Faroe Islands

    L.L. Farrell, E. Nosova, S. Bech, I. Guella, M.J. Farrer, M.S. Petersen (Vancouver, BC, Canada)

    Objective: To investigate genetic variability in CYP2B6, PCB levels and Parkinson's disease in the Faroese. Background: Polychlorinated biphenyls (PCBs) are persistent man-made highly toxic pollutants…
  • 2016 International Congress

    Epigenome-wide association study of Parkinson’s disease

    B. Ritz, Y.H. Chuang, S. Horvath, Y. Bordelon, J. Bronstein (Los Angeles, CA, USA)

    Objective: To identify gene-specific DNA methylation associated with Parkinson's disease (PD). Background: There is a growing interest in the role of epigenetic DNA methylation (DNAm)…
  • 2016 International Congress

    Carrier mediated delivery system bearing dopamine for effective management of parkinsonism

    V. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposome bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2016 International Congress

    α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease

    H. Sumikura, J. Fujigasaki, Y. Nakano, A. Uchino, Y. Saito, H. Mochizuki, S. Murayama (Tokyo, Japan)

    Objective: To examine whether the degree of α-synuclein (α-Syn) in the peripheral organs of patients with Lewy body disease (LBD: Parkinson's disease, dementia with Lewy…
  • 2016 International Congress

    A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease

    J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor (Herts, United Kingdom)

    Objective: To comprehensively characterise the salivary proteome of patients with Parkinson's disease (PD) and generate potential biomarker candidates for future studies. Background: Saliva may be…
  • 2016 International Congress

    Vitamin D in early Parkinson’s disease

    I.M. Sleeman, T. Aspray, S. Coleman, G. Duncan, T.K. Khoo, I. Schoenmakers, L. Rochester, D.J. Burn, A.J. Yarnall (Newcastle, United Kingdom)

    Objective: To determine serum 25-hydroxy vitamin D (25OHD) concentration at diagnosis and 18 months in incident Parkinson's disease (PD) compared to controls and to investigate…
  • 2016 International Congress

    Microglia P2Y6 receptor is related to Parkinson’s disease and involved in the neuroinflammatory process

    X. Yang, Y. Lou, X. Wang, G. Liu, Y. Qian, J. Ding, S. Chen, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate whether the purinoceptor P2Y6 can be used as a biomarker in the diagnosis and treatment of Parkinson's disease (PD) and the role…
  • 2016 International Congress

    Gait initiation in response to emotion-inducing pictures in Parkinson’s disease

    L. Avanzino, G. Lagravinese, A. Ravaschio, E. Pelosin, G. Abbruzzese (Genoa, Italy)

    Objective: To investigate gait initiation in response to emotion inducing pictures in subjects with Parkinson's disease (PD). Background: Novel pathophysiological models have linked gait disturbances…
  • 2016 International Congress

    Monitoring oxidative stress and progression to cell death: From secretome to blood diagnosis

    S.I. Anjo, V.M. Mendes, M. Grãos, B. MAnadas (Cantanhede, Portugal)

    Objective: To achieve a comprehensive method able to distinguish the secretome changes caused by oxidative stress regulation or induction of cell death, and thus be…
  • 2016 International Congress

    Faithful SGCE imprinting in iPSC-derived cortical neurons: An endogenous model system of myoclonus-dystonia

    K. Grütz, P. Seibler, A. Weißbach, K. Lohmann, F.A. Carlisle, D.J. Blake, A. Westenberger, C. Klein, A. Grünewald (Lübeck, Germany)

    Objective: To test the potential of induced pluripotent stem cell (iPSC)-derived cortical neurons from Myoclonus-dystonia (M-D) patients when studying specific epigenetic and brain-specific aspects of…
  • « Previous Page
  • 1
  • …
  • 1750
  • 1751
  • 1752
  • 1753
  • 1754
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley